Detalles de la búsqueda
1.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature;
606(7915): 797-803, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705814
2.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature;
613(7945): E3, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627494
3.
Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma.
Br J Cancer;
127(5): 937-947, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618788
4.
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.
Mol Cell Proteomics;
17(6): 1245-1258, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531020
5.
Identification and validation of a prognostic proteomic signature for cervical cancer.
Gynecol Oncol;
155(2): 324-330, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31477280
6.
Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.
J Lipid Res;
57(1): 25-35, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25977291
7.
Assembly and function of the regulator of G protein signaling 14 (RGS14)·H-Ras signaling complex in live cells are regulated by Gαi1 and Gαi-linked G protein-coupled receptors.
J Biol Chem;
288(5): 3620-31, 2013 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23250758
8.
Ataxia-Telangiectasia Mutated (ATM) loss of function displays variant and tissue-specific differences across tumor types.
Clin Cancer Res;
2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416404
9.
RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory.
Proc Natl Acad Sci U S A;
107(39): 16994-8, 2010 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20837545
10.
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
Mol Cancer Res;
21(1): 51-61, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112348
11.
Combined KRASG12C and SOS1 inhibition enhances and extends the anti-tumor response in KRASG12C-driven cancers by addressing intrinsic and acquired resistance.
bioRxiv;
2023 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36747713
12.
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.
Nat Med;
29(1): 115-126, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658425
13.
G protein-coupled receptors and resistance to inhibitors of cholinesterase-8A (Ric-8A) both regulate the regulator of g protein signaling 14 RGS14·Gαi1 complex in live cells.
J Biol Chem;
286(44): 38659-38669, 2011 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21880739
14.
Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma.
Mol Oncol;
16(5): 1132-1152, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34632715
15.
PGC1α/ß Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.
Cancer Res;
82(7): 1423-1434, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131872
16.
Activation of the regulator of G protein signaling 14-Gαi1-GDP signaling complex is regulated by resistance to inhibitors of cholinesterase-8A.
Biochemistry;
50(5): 752-62, 2011 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21158412
17.
Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL.
Blood Adv;
5(16): 3134-3146, 2021 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34424317
18.
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.
Blood Adv;
5(20): 4233-4255, 2021 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507353
19.
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer.
Cancer Res;
81(21): 5572-5581, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518211
20.
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.
Clin Cancer Res;
27(23): 6354-6365, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518313